Patent · US Active

Kit for preparation of target radiopharmaceuticals and method of using it

US9717808B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

INSTITUTE OF NUCLEAR ENERGY RESEARCH, ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN · TW

Inventors

Shu-Pei Chiu · Daxi District, TW
Bo-Sian Lin · Taipei, TW
Liang Lin · Longbeilingcun, CN
Yi-Jang Lee · Taipei, TW
Te-Wei Lee · Daxi District, TW
Feng-Yun Huang · Wanrong, TW
Jem-Mau Lo · Hengshan, TW

Key dates

Filing date	Nov 3, 2014
Grant date	Aug 1, 2017
Priority date	—
Expiry date	Aug 10, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a kit for preparation of target radiopharmaceuticals, a method of using the kit to prepare target radiopharmaceuticals and use of the target radiopharmaceuticals. The target radiopharmaceuticals comprise a radio-nuclear loading on liposome and inhibit the tumor growth and metastatic progression of head and neck cancer, lung cancer and brain cancer. The radiopharmaceuticals may be used for treating the mentioned cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.